Edap Tms (EDAP) Competitors

$4.33 +0.00 (+0.07%)

As of 04:00 PM Eastern

EDAP vs. SIBN, TCMD, MDXG, NPCE, and KIDS

Should you buy Edap Tms stock or one of its competitors? MarketBeat compares Edap Tms with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Edap Tms include SiBone (SIBN), Tactile Systems Technology (TCMD), MiMedx Group (MDXG), NeuroPace (NPCE), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

How does Edap Tms compare to SiBone?

Edap Tms (NASDAQ:EDAP) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

In the previous week, SiBone had 2 more articles in the media than Edap Tms. MarketBeat recorded 4 mentions for SiBone and 2 mentions for Edap Tms. Edap Tms' average media sentiment score of 0.00 beat SiBone's score of -0.22 indicating that Edap Tms is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SiBone	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Edap Tms currently has a consensus price target of $6.00, indicating a potential upside of 37.96%. SiBone has a consensus price target of $23.00, indicating a potential upside of 56.78%. Given SiBone's stronger consensus rating and higher probable upside, analysts plainly believe SiBone is more favorable than Edap Tms.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 4.0% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SiBone has higher revenue and earnings than Edap Tms. SiBone is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$70.53M	2.31	-$29.25M	-$0.81	N/A
SiBone	$200.93M	3.24	-$18.90M	-$0.39	N/A

Edap Tms has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market. Comparatively, SiBone has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

SiBone has a net margin of -8.10% compared to Edap Tms' net margin of -41.47%. SiBone's return on equity of -9.56% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-41.47%	-137.61%	-40.62%
SiBone	-8.10%	-9.56%	-7.06%

Summary

SiBone beats Edap Tms on 14 of the 16 factors compared between the two stocks.

How does Edap Tms compare to Tactile Systems Technology?

Edap Tms (NASDAQ:EDAP) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Tactile Systems Technology had 4 more articles in the media than Edap Tms. MarketBeat recorded 6 mentions for Tactile Systems Technology and 2 mentions for Edap Tms. Tactile Systems Technology's average media sentiment score of 0.69 beat Edap Tms' score of 0.00 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tactile Systems Technology	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$70.53M	2.31	-$29.25M	-$0.81	N/A
Tactile Systems Technology	$329.52M	1.71	$19.09M	$0.88	28.32

Edap Tms has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

62.7% of Edap Tms shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Tactile Systems Technology has a net margin of 5.91% compared to Edap Tms' net margin of -41.47%. Tactile Systems Technology's return on equity of 9.70% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-41.47%	-137.61%	-40.62%
Tactile Systems Technology	5.91%	9.70%	7.53%

Edap Tms currently has a consensus price target of $6.00, suggesting a potential upside of 37.96%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 54.86%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts plainly believe Tactile Systems Technology is more favorable than Edap Tms.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Summary

Tactile Systems Technology beats Edap Tms on 16 of the 17 factors compared between the two stocks.

How does Edap Tms compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

MiMedx Group has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Edap Tms has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market.

MiMedx Group has a net margin of 7.88% compared to Edap Tms' net margin of -41.47%. MiMedx Group's return on equity of 21.03% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Edap Tms	-41.47%	-137.61%	-40.62%

In the previous week, MiMedx Group had 1 more articles in the media than Edap Tms. MarketBeat recorded 3 mentions for MiMedx Group and 2 mentions for Edap Tms. MiMedx Group's average media sentiment score of 0.22 beat Edap Tms' score of 0.00 indicating that MiMedx Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MiMedx Group has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.29	$48.58M	$0.20	18.13
Edap Tms	$70.53M	2.31	-$29.25M	-$0.81	N/A

79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 62.7% of Edap Tms shares are held by institutional investors. 2.5% of MiMedx Group shares are held by company insiders. Comparatively, 0.2% of Edap Tms shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

MiMedx Group currently has a consensus target price of $8.50, suggesting a potential upside of 134.48%. Edap Tms has a consensus target price of $6.00, suggesting a potential upside of 37.96%. Given MiMedx Group's stronger consensus rating and higher possible upside, equities analysts plainly believe MiMedx Group is more favorable than Edap Tms.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Edap Tms	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

MiMedx Group beats Edap Tms on 15 of the 16 factors compared between the two stocks.

How does Edap Tms compare to NeuroPace?

Edap Tms (NASDAQ:EDAP) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Edap Tms currently has a consensus target price of $6.00, indicating a potential upside of 37.96%. NeuroPace has a consensus target price of $18.83, indicating a potential upside of 11.62%. Given Edap Tms' higher possible upside, research analysts clearly believe Edap Tms is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 20.5% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NeuroPace has a net margin of -21.67% compared to Edap Tms' net margin of -41.47%. NeuroPace's return on equity of -108.20% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-41.47%	-137.61%	-40.62%
NeuroPace	-21.67%	-108.20%	-18.50%

Edap Tms has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market. Comparatively, NeuroPace has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market.

In the previous week, NeuroPace had 9 more articles in the media than Edap Tms. MarketBeat recorded 11 mentions for NeuroPace and 2 mentions for Edap Tms. NeuroPace's average media sentiment score of 0.74 beat Edap Tms' score of 0.00 indicating that NeuroPace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeuroPace	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroPace has higher revenue and earnings than Edap Tms. NeuroPace is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$70.53M	2.31	-$29.25M	-$0.81	N/A
NeuroPace	$99.99M	5.75	-$21.47M	-$0.65	N/A

Summary

NeuroPace beats Edap Tms on 15 of the 17 factors compared between the two stocks.

How does Edap Tms compare to OrthoPediatrics?

Edap Tms (NASDAQ:EDAP) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Edap Tms has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

Edap Tms has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$70.53M	2.31	-$29.25M	-$0.81	N/A
OrthoPediatrics	$236.35M	2.00	-$39.65M	-$1.68	N/A

Edap Tms currently has a consensus price target of $6.00, suggesting a potential upside of 37.96%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 32.96%. Given Edap Tms' higher possible upside, equities analysts clearly believe Edap Tms is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

OrthoPediatrics has a net margin of -16.31% compared to Edap Tms' net margin of -41.47%. OrthoPediatrics' return on equity of -7.01% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-41.47%	-137.61%	-40.62%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

In the previous week, Edap Tms had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 2 mentions for Edap Tms and 1 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.57 beat Edap Tms' score of 0.00 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

OrthoPediatrics beats Edap Tms on 11 of the 17 factors compared between the two stocks.

Get Edap Tms News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EDAP vs. The Competition

Export

Metric	Edap Tms	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$163.00M	$6.96B	$6.40B	$12.33B
Dividend Yield	N/A	1.67%	2.79%	5.33%
P/E Ratio	-5.37	49.31	21.02	25.75
Price / Sales	2.31	83.85	579.61	98.92
Price / Cash	N/A	25.00	44.13	56.16
Price / Book	16.11	6.43	10.08	7.03
Net Income	-$29.25M	$158.81M	$3.56B	$335.04M
7 Day Performance	4.29%	3.41%	4.80%	2.72%
1 Month Performance	29.05%	-1.96%	1.43%	1.53%
1 Year Performance	141.61%	1.96%	36.01%	35.73%

Edap Tms Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EDAP Edap Tms	3.2618 of 5 stars	$4.35 +0.4%	$6.00 +38.0%	+148.9%	$163.00M	$70.53M	N/A	230
SIBN SiBone	2.3887 of 5 stars	$13.29 +14.5%	$23.67 +78.0%	-22.5%	$585.03M	$200.93M	N/A	350	Insider Trade High Trading Volume
TCMD Tactile Systems Technology	4.1847 of 5 stars	$23.75 -0.6%	$38.60 +62.5%	+160.2%	$534.56M	$329.52M	26.93	1,086	Analyst Forecast
MDXG MiMedx Group	3.6845 of 5 stars	$3.57 +0.1%	$8.50 +138.4%	-47.7%	$529.52M	$418.63M	17.78	870
NPCE NeuroPace	3.2351 of 5 stars	$15.64 -0.2%	$18.67 +19.3%	-10.2%	$528.67M	$99.99M	N/A	170	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EDAP) was last updated on 5/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edap Tms (EDAP) Competitors

EDAP vs. SIBN, TCMD, MDXG, NPCE, and KIDS

How does Edap Tms compare to SiBone?

Summary

How does Edap Tms compare to Tactile Systems Technology?

Summary

How does Edap Tms compare to MiMedx Group?

Summary

How does Edap Tms compare to NeuroPace?

Summary

How does Edap Tms compare to OrthoPediatrics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP vs. The Competition

Edap Tms Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edap Tms (EDAP) Competitors

EDAP vs. SIBN, TCMD, MDXG, NPCE, and KIDS

How does Edap Tms compare to SiBone?

Does the media favor EDAP or SIBN?

Do analysts recommend EDAP or SIBN?

Do insiders & institutionals have more ownership in EDAP or SIBN?

Which has higher valuation and earnings, EDAP or SIBN?

Which has more volatility and risk, EDAP or SIBN?

Is EDAP or SIBN more profitable?

Summary

How does Edap Tms compare to Tactile Systems Technology?

Does the media favor EDAP or TCMD?

Which has stronger earnings and valuation, EDAP or TCMD?

Which has more volatility & risk, EDAP or TCMD?

Do insiders and institutionals hold more shares of EDAP or TCMD?

Is EDAP or TCMD more profitable?

Do analysts recommend EDAP or TCMD?

Summary

How does Edap Tms compare to MiMedx Group?

Which has more volatility and risk, MDXG or EDAP?

Is MDXG or EDAP more profitable?

Does the media prefer MDXG or EDAP?

Which has better valuation and earnings, MDXG or EDAP?

Do institutionals & insiders have more ownership in MDXG or EDAP?

Do analysts rate MDXG or EDAP?

Summary

How does Edap Tms compare to NeuroPace?

Do analysts rate EDAP or NPCE?

Do insiders and institutionals believe in EDAP or NPCE?

Is EDAP or NPCE more profitable?

Which has more volatility & risk, EDAP or NPCE?

Does the media prefer EDAP or NPCE?

Which has preferable earnings and valuation, EDAP or NPCE?

Summary

How does Edap Tms compare to OrthoPediatrics?

Do insiders & institutionals hold more shares of EDAP or KIDS?

Which has more volatility & risk, EDAP or KIDS?

Which has better valuation & earnings, EDAP or KIDS?

Do analysts prefer EDAP or KIDS?

Is EDAP or KIDS more profitable?

Does the media favor EDAP or KIDS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP vs. The Competition

Edap Tms Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools